Alethea Capital Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.48M Buy
949,285
+290,108
+44% +$1.67M 4.15% 5
2025
Q1
$4.35M Buy
659,177
+100,735
+18% +$665K 3.25% 5
2024
Q4
$4.86M Buy
558,442
+4,900
+0.9% +$42.7K 4.16% 4
2024
Q3
$10.8M Buy
553,542
+287,636
+108% +$5.62M 7.81% 4
2024
Q2
$5.48M Buy
265,906
+6,300
+2% +$130K 4.15% 4
2024
Q1
$5.54M Sell
259,606
-90,839
-26% -$1.94M 4.5% 4
2023
Q4
$5.04M Hold
350,445
5.81% 3
2023
Q3
$3.2M Buy
350,445
+17,000
+5% +$155K 3.93% 3
2023
Q2
$3.53M Sell
333,445
-30,328
-8% -$321K 3.77% 3
2023
Q1
$4.45M Hold
363,773
4.7% 3
2022
Q4
$4.51M Sell
363,773
-2,796
-0.8% -$34.7K 4.33% 4
2022
Q3
$5.01M Hold
366,569
6.33% 4
2022
Q2
$6.72M Buy
366,569
+8,949
+3% +$164K 8.41% 3
2022
Q1
$5.75M Buy
357,620
+271,820
+317% +$4.37M 5.2% 4
2021
Q4
$1.2M Buy
+85,800
New +$1.2M 1.02% 7
2021
Q1
Sell
-67,568
Closed -$2.21M 94
2020
Q4
$2.21M Sell
67,568
-48,073
-42% -$1.57M 1.11% 8
2020
Q3
$3.54M Sell
115,641
-100,530
-47% -$3.08M 2.4% 5
2020
Q2
$3.52M Sell
216,171
-102,821
-32% -$1.68M 2.06% 6
2020
Q1
$3.17M Buy
318,992
+52,465
+20% +$522K 2.06% 4
2019
Q4
$3.67M Hold
266,527
1.57% 4
2019
Q3
$4.04M Hold
266,527
2.56% 4
2019
Q2
$5.25M Buy
266,527
+27,611
+12% +$544K 3.42% 4
2019
Q1
$3.96M Buy
238,916
+21,166
+10% +$351K 2.82% 4
2018
Q4
$3.06M Buy
217,750
+2,088
+1% +$29.3K 4.45% 3
2018
Q3
$3.77M Hold
215,662
5.66% 2
2018
Q2
$3.93M Buy
215,662
+35,067
+19% +$638K 6.7% 2
2018
Q1
$3.39M Buy
180,595
+90,922
+101% +$1.7M 4.59% 2
2017
Q4
$1.37M Sell
89,673
-22,000
-20% -$337K 2.18% 4
2017
Q3
$1.67M Buy
111,673
+15,000
+16% +$224K 1.96% 20
2017
Q2
$899K Buy
96,673
+11,904
+14% +$111K 1.02% 31
2017
Q1
$746K Buy
84,769
+20,469
+32% +$180K 0.9% 33
2016
Q4
$379K Hold
64,300
0.48% 52
2016
Q3
$402K Buy
64,300
+2,300
+4% +$14.4K 0.56% 48
2016
Q2
$168K Buy
+62,000
New +$168K 0.23% 57